The use of a ketamine-propofol combination during monitored anesthesia care

Anesthesia and Analgesia

Volumn 90, Issue 4, 2000, Pages 858-862

  Badrinath, Shyamala ^a   Avramov, Michail N ^a   Shadrick, Melissa ^a   Witt, Thomas R ^a   Ivankovich, Anthony D ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; MIDAZOLAM; OPIATE DERIVATIVE; PROPOFOL; SUFENTANIL;

ADULT; AGED; AMBULATORY SURGERY; ANESTHETIC RECOVERY; ARTICLE; BREAST BIOPSY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; PATIENT MONITORING; POSTOPERATIVE ANALGESIA; POSTOPERATIVE NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION;

EID: 0034112148     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200004000-00016     Document Type: Article

References (17)

1. Avramov MN, Smith I, White PF. Interactions between midazolam and remifentanil during monitored anesthesia care. Anesthesiology 1996;85:1283-9.
2. Avramov MN, White PF. Use of alfentanil and propofol for outpatient monitored anesthesia care: determining the optimal dosing regimen. Anesth Analg 1997;85:566-72.
3. White PF, Way WL, Trevor AJ: Ketamine: its pharmacology and therapeutic uses. Anesthesiology 1982;56:119-36.
4. Guit JBM, Koning HM, Coster ML, et al. Ketamine as analgesic for total intravenous anaesthesia with propofol. Anaesthesia 1990;46:24-7.
5. Clements A, Nimmo WS, Grant IS. Bioavailability, pharmaco-kinetics and analgesic activity of ketamine in humans. J Pharm Sci 1979;71:539-41.
6. Idvall J, Ahlgren I, Aronson KF, et al. Ketamine infusions: pharmacokinetics and clinical effects. Br J Anaesth 1979;51: 1167-72.
7. Friedberg BL. Propofol-ketamine technique. Aesth Plast Surg 1993;17:297-300.
8. Frizelle HP, Duranteau J, Samii K. A comparison of propofol with a propofol-ketamine combination for sedation during spinal anesthesia. Anesth Analg 1997;84:1318-22.
9. Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychpharmacol 1990;10: 244-51.
10. Avramov MN, White PF. Methods for monitoring the level of sedation. Critical Care Clinics 1995;11:803-26.
11. Bowdle TA, Radant AD, Cowley DS, et al. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology 1998;88:82-8.
12. Krystal JH, Karper LP, Seibyl JP, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994;51:199-214.
13. Hui TW, Short TG, Hong W, et al. Additive interactions between propofol and ketamine when used for anesthesia induction in female patients. Anesthesiology 1995;84:641-8.
14. Mori K, Kawamata M, Mitani H, et al. A neurophysiologic study of ketamine anesthesia in the cat. Anesthesiology 1971;35: 373-83.
15. Tomoda K, Shingu K, Osawa M, et al. Comparison of CNS effects of propofol and thiopentone in cats. Br J Anaesth 1993; 71:383-7.
16. Schuttler J, Zsigmond EK, White PF. Ketamine and its isomers. In: White PF, ed. Textbook of intravenous anesthesia. Baltimore: Williams & Wilkins, 1997:171-188.
17. Morel DR, Forster A, Gemperle M. Noninvasive evaluation of breathing pattern and thoracoabdominal motion following infusion of ketamine or droperidol in humans. Anesthesiology, 1986;65:392-8.